Neo Medical announced a CHF 13.2 million financing led by 4FO Venture Partners. investiere contributed CHF 1.4 million to this round.

Neo Medical has developed a Swiss-made toolset for spine surgery. It has already been used in more than 250 hospitals. Its ease of use has convinced surgeons. It reduces complexity, operating time, and the risk of infections. Instead of several hundred parts, it uses five instruments and fourteen implants only, and it still does a better job, potentially reducing risks of screw loosening, hardware failure, and eventually further reducing re-operation risks, while improving overall patient outcomes. To enhance safety, Neo’s screws and implants are sterile and single-use, which removes the need for sterilization in the hospital. This reduces the environmental footprint of spinal fusion surgery by 75% versus legacy reusable systems.

Along with the financing round, Neo Medical announced that two leading Medtech professionals are joining the company Board: Michel Orsinger as Member, and Oern Stuge as Chairman of Neo Medical Board of Directors.

“They have developed a truly innovative product that is drastically reducing the complexity of spine surgeries and operating time necessary”, said Michael Lütolf, Investment Manager at investiere.

“The financing round announced today is an important milestone for Neo Medical as we look at scaling sales and distribution up in our five strategic markets”, said Vincent Lefauconnier, CEO of Neo Medical.

“Neo Medical came to us with a brilliant and fundamentally new concept that was driven by input from the market, the surgeons”, said Christoph Ruetschi, whose family firm is Neo Medical’s manufacturing partner.